Reverse microdialysis of a dopamine D2 receptor antagonist alters extracellular adenosine levels in the rat nucleus accumbens

Neurochemistry International

Volumn 44, Issue 8, 2004, Pages 609-615

  Nagel, J ^a   Hauber, W ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Microdialysis; Raclopride

Indexed keywords

ADENOSINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIALYSATE; HOMEOSTASIS; MALE; METABOLISM; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ADENOSINE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE ANTAGONISTS; EXTRACELLULAR SPACE; FLUOROMETRY; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; STEREOTAXIC TECHNIQUES;

EID: 1542358090     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2003.10.001     Document Type: Article

References (65)

1. Ballarin M., Fredholm B.B., Ambrosio S., Mahy N. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol. Scand. 142:1991;97-103.
2. Barraco R.A., Martens K.A., Parizon M., Normile H.J. Role of adenosine A2a receptors in the nucleus accumbens. Prog. Neuropsychopharm. Biol. Psychiatry. 18:1994;545-553.
3. Chartoff E.H., Ward R.P., Dorsa D.M. Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy. J. Pharmacol. Exp. Ther. 291:1999;531-537.
4. Chen Y., Graham D.I., Stone T.W. Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo. Br. J. Pharmacol. 106:1992;632-638.
5. Craig C.G., White T.D. N-Methyl-D-aspartate- and non-N-methyl-D- aspartate evoked adenosine release from cortical slices: distinct purinergic sources and mechanisms of release. J. Neurochem. 60:1993;1073-1080.
6. Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 38:2001;107-125.
7. Delaney S.M., Geiger J.D. Levels of endogenous adenosine in rat striatum. II. Regulation of basal and N-methyl-D-aspartate-induced levels by inhibitors of adenosine transport and metabolism. J. Pharmacol. Exp. Ther. 285:1998;568-572.
8. Delaney S.M., Shepel P.N., Geiger J.D. Levels of endogenous adenosine in rat striatum. I. Regulation by ionotropic glutamate receptors, nitric oxide and free radicals. J. Pharmacol. Exp. Ther. 285:1998;561-567.
9. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24:2001;31-55.
10. Fenu S., Cauli O., Morelli M. Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A(2A) receptors. Behav. Brain Res. 114:2000;97-105.
11. Fenu S., Morelli M. Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors. Eur. J. Neurosci. 10:1998;1878-1884.
12. Ferre S. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology. 133:1997;107-120.
13. Ferre S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487.
14. Ferre S., O'Connor W.T., Snaprud P., Ungerstedt U., Fuxe K. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience. 63:1994;765-773.
15. Fredholm B.B. Purinoceptors in the nervous system. Pharmacol. Toxicol. 76:1995;228-239.
16. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
17. Freeman K.A., Tallarida R.J. A quantitative study of dopamine control in the rat striatum. J. Pharmacol. Exp. Ther. 268:1994;629-638.
18. Fuxe K., Ferre S., Zoli M., Agnati L.F. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res. Brain Res. Rev. 26:1998;258-273.
19. Gerfen C.R. Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci. 23:2000;64-70.
20. Hagberg H., Andersson P., Lacarewicz J., Jacobson I., Butcher S., Sandberg M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem. 49:1987;227-231.
21. Hall H., Kohler C., Gawell L., Farde L., Sedvall G. Raclopride, a new selective ligand for the dopamine-D2 receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry. 12:1988;559-568.
22. Hauber W., Koch M. Adenosine A2a receptors in the nucleus accumbens modulate prepulse inhibition of the startle response. Neuroreport. 8:1997;1515-1518.
23. Hauber W., Munkle M. Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. Eur. J. Pharmacol. 323:1997;127-131.
24. Hauber W., Nagel J., Sauer R., Muller C.E. Motor effects induced by a blockade of adenosine A2A receptors in the caudate-putamen. Neuroreport. 9:1998;1803-1806.
25. Hauber W., Neuscheler P., Nagel J., Muller C.E. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats. Eur. J. Neurosci. 14:2001;1287-1293.
26. Imperato A., Di Chiara G. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur. J. Pharmacol. 156:1988;385-393.
27. Jin S., Fredholm B.B. Glucose deprivation increases basal and electrically evoked transmitter release from rat striatal slices. Role of NMDA and adenosine A1 receptors. Eur. J. Pharmacol. 340:1997;169-175.
28. Kafka S.H., Corbett R. Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia. Eur. J. Pharmacol. 295:1996;147-154.
29. Kanda T., Shiozaki S., Shimada J., Suzuki F., Nakamura J. KF17837: a novel selective adenosine A(2A) receptor antagonist with anticataleptic activity. Eur. J. Pharm. 256:1994;263.
30. Kelley A.E. Neural integrative activities of nucleus accumbens subregiones in relation to learning and motivation. Psychobiology. 27:1999;198-213.
31. Latini S., Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79:2001;463-484.
32. LeMoine C., Svenningsson P., Fredholm B.B., Bloch B. Dopamine-adenosine interactions in the striatum and the Globus pallidus: inhibition of Striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects. J. Neurosci. 17:1997;8038-8048.
33. Manzoni O.J., Manabe T., Nicoll R.A. Release of adenosine by activation of NMDA receptors in the hippocampus. Science. 265:1994;2098-2101.
34. Marston H.M., Finlayson K., Maemoto T., Olverman H.J., Akahane A., Sharkey J., Butcher S.P. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques. J. Pharmacol. Exp. Ther. 285:1998;1023-1030.
35. Melani A., Corsi C., Gimenez-Llort L., Martinez E., Ogren S.O., Pedata F., Ferre S. Effect of N-methyl-D-aspartate on motor activity and in vivo adenosine striatal outflow in the rat. Eur. J. Pharmacol. 385:1999a;15-19.
36. Melani A., Pantoni L., Corsi C., Bianchi L., Monopoli A., Bertorelli R., Pepeu G., Pedata F. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke. 30:1999b;2448-2454. discussion 2455.
37. Morrison, P.F., Bungay, P.M., Hsiao, J.K., Mefford, I.N., Dykstra, K.H., Dedrick R.L., 1991. Quantitative microdialysis, in: Huston, J.P. (Ed.), Microdialysis in the Neurosciences. Elsevier, Amsterdam, pp. 47-59.
38. Nagel J., Schladebach H., Schwienbacher I., Koch M., Müller C.E., Hauber W. Effects of adenosine A2A receptor blockade in the nucleus accumbens on locomotion, feeding, and prepulse inhibition in rats. Synapse. 49:2003;279-286.
39. Ögren S.O., Fuxe K. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways. Neurosci. Lett. 85:1988;333-338.
40. Ongini E., Fredholm B.B. Pharmacology of adenosine A2A receptors. Trends Pharmacol. Sci. 17:1996;364-372.
41. Ouagazzal A., Amalric M. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism. Eur. J. Pharm. 294:1995;137.
42. Ozer H., Ekinci A.C., Starr M.S. Dopamine D-1- and D-2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata. Brain Res. 777:1997;51-59.
43. Pellegrino, L.J., Pellegrino, A.S., Cushmann, A.J., 1981. A Stereotaxic Atlas of the Rat Brain. Plenum Press, New York.
44. Pinna A., Corsi C., Carta A.R., Valentini V., Pedata F., Morelli M. Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation. Eur. J. Pharmacol. 446:2002;75-82.
45. Popoli P., Reggio R., Pezzola A., Fuxe K., Ferre S. Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats. Neurosci. Lett. 251:1998;201-204.
46. Rahman S., McBride W.J. Feedback control of mesolimbic somatodendritic dopamine release in rat brain. J. Neurochem. 74:2000;684-692.
47. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:1998;413-492.
48. Robbins T.W., Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr. Opin. Neurobiol. 6:1996;228-236.
49. Rosin D.L., Robeva A., Woodard R.L., Guyenet P.G., Linden J. Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J. Comp. Neurol. 401:1998;163-186.
50. Rudolphi K.A., Schubert P. Modulation of neuronal and glial cell function by adenosine and neuroprotection in vascular dementia. Behav. Brain Res. 83:1997;123-128.
51. Saulskaya N.B., Mikhailova M.O. Feeding-induced decrease in extracellular glutamate level in the rat nucleus accumbens: dependence on glutamate uptake. Neuroscience. 112:2002;791-801.
52. Secrist J.A., Barrio J.R., Leonard N.J., Weber G. Fluorescent modification of adenosine-containing coenzymes. Biological activities and spectroscopic properties. Biochemistry. 11:1972;3499-3506.
53. Seeman P., Ulpian C. Dopamine D1 and D2 receptor selectivities of agonists and antagonists. Adv. Exp. Med. Biol. 235:1988;55-63.
54. Strecker R.E., Morairty S., Thakkar M.M., Porkka-Heiskanen T., Basheer R., Dauphin L.J., Rainnie D.G., Portas C.M., Greene R.W., McCarley R.W. Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav. Brain Res. 115:2000;183-204.
55. Svenningsson P., Fredholm B.B. Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus. Neuropharmacology. 36:1997;1309-1317.
56. Svenningsson P., Nomikos G.G., Fredholm B.B. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J. Neurosci. 19:1999;4011-4022.
57. Thermos K., Radke J., Kastellakis A., Anagnostakis Y., Spyraki C. Dopamine-somatostatin interactions in the rat striatum: an in vivo microdialysis study. Synapse. 22:1996;209-216.
58. Turgeon S.M., Pollack A.E., Schusheim L., Fink J.S. Effects of selective adenosine A1 and A2a agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens. Brain Res. 707:1996;75-80.
59. van den Boss R., Cools A.R., Ogren S.O. Differential effects of the selective D2-antagonist raclopride in the nucleus accumbens of the rat on spontaneous and D-amphetamine-induced activity. Psychopharmacology. 95:1988;447-451.
60. von Lubitz D.K. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? [corrected and republished article originally printed in Eur. J. Pharmacol. 1999;365(1):9-25]. Eur. J. Pharmacol. 371:1999;85-102.
61. Ward R.P., Dorsa D.M. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration. Neuroscience. 89:1999;927-938.
62. West A.R., Grace A.A. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J. Neurosci. 22:2002;294-304.
63. Westerink B.H. Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 70:1995;103-124.
64. Wojcik W.J., Neff N.H. Adenosine measurement by a rapid HPLC-fluorometric method: induced changes of adenosine content in regions of rat brain. J. Neurochem. 39:1982;280-282.
65. Zahniser N.R., Simosky J.K., Mayfield R.D., Negri C.A., Hanania T., Larson G.A., Kelly M.A., Grandy D.K., Rubinstein M., Low M.J., Fredholm B.B. Functional uncoupling of adenosine A(2A) receptors and reduced response to caffeine in mice lacking dopamine D2 receptors. J. Neurosci. 20:2000;5949-5957.